Observational studyBritish journal of haematology2016
Real-world clinical experience in the Connect
Observational study in British journal of haematology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01081015 (Connect™ CLL), which is not on this map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Who cites it
25 citing papers in PubMed, 43 citations in OpenAlex.
- Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study.Cancer medicine · 2018Trial
- Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States.BMC cancer · 2017Trial
- How Do We Manage Chronic Lymphocytic Leukemia in India.Current hematologic malignancy reports · 2024Review
- Article
- A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib.Haematologica · 2022Article
- Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea.Blood research · 2021Article
- Real World Treatment Practices for Chronic Lymphocytic Leukemia in Japan: An Observational Database Research Study (CLIMBER-DBR).Journal of clinical and experimental hematopathology : JCEH · 2021Article
- CRIS: complete reconstruction of immunoglobulinBioinformatics advances · 2021Article
- Article
- Article
- Chronic Lymphocytic Leukemia: Real-World Data From India.JCO global oncology · 2020Article
- The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.Cancer medicine · 2020Article
- The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites.Blood advances · 2020Observational
- Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL Registry.Clinical lymphoma, myeloma & leukemia · 2020Article
- Descriptive analysis of dosing and outcomes for patients with ibrutinib-treated relapsed or refractory chronic lymphocytic leukemia in a Canadian centre.Current oncology (Toronto, Ont.) · 2019Article
- Real-world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis.Cancer · 2019Article
- Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.American journal of hematology · 2018Article
- Article
- Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review.Haematologica · 2018Review
- Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis.Haematologica · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 11 institutions in 1 country.
Funding
Abstract
The clinical course of chronic lymphocytic leukaemia (CLL) is heterogeneous, and treatment options vary considerably. The Connect
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.